Hemolytic Anemia

This is a type of anemia where red blood cells are destroyed faster than they can be made. This destruction can happen inside the body or outside the body. It can cause fatigue and weakness. There are different types, some are inherited and some are acquired.

Condition

What people with Hemolytic Anemia report

Every report comes from a Lived member, sent anonymously.

Have you tried Prednisone for Hemolytic Anemia?

NameHow it went

About Hemolytic Anemia

What It Is

Hemolytic anemia is a type of anemia in which red blood cells are destroyed faster than the bone marrow can replace them. Red blood cells carry oxygen from the lungs to the rest of the body and normally last about 120 days. When they break down early, the body ends up short of oxygen-carrying cells, which can cause tiredness, weakness, shortness of breath and a fast or pounding heartbeat. The breakdown itself leaves recognizable traces. Hemoglobin from destroyed cells is turned into bilirubin, a yellow pigment, so people may notice yellowing of the skin or the whites of the eyes (jaundice) or dark urine. The spleen, which filters damaged cells out of the blood, can become enlarged. Hemolytic anemia is an umbrella term rather than a single disease: it can be inherited or acquired, sudden or slow, and mild enough to need no treatment or serious enough to need urgent care.

Causes & Risk Factors

Some causes are inherited and present from birth. Sickle cell disease and thalassemia change hemoglobin, the oxygen-carrying protein inside red cells. Other inherited conditions affect the protein framework that keeps red cells flexible, or an enzyme that protects them. In G6PD (glucose-6-phosphate dehydrogenase) deficiency, for example, a person may have no symptoms until certain medicines, foods, infections or stress trigger a sudden episode of red cell breakdown. Other causes are acquired later in life. In autoimmune hemolytic anemia, the immune system makes antibodies against the body's own red cells. This can happen on its own or alongside conditions such as lupus or some lymphomas. Certain medicines and infections can damage red cells directly or set off an immune reaction. Red cells can also be torn apart mechanically, by tiny clots in small blood vessels (microangiopathic hemolytic anemia) or by a damaged or artificial heart valve. A transfusion of mismatched blood is a rarer cause.

How It's Diagnosed

Diagnosis usually starts with a complete blood count (CBC), which measures red cells, hemoglobin and hematocrit (the share of blood made up of red cells) and shows whether anemia is present. Further blood tests then show whether red cells are being destroyed. A high reticulocyte count means the marrow is releasing young red cells quickly to make up for losses. Raised lactate dehydrogenase (LDH, an enzyme released from broken cells) and unconjugated bilirubin, together with a low haptoglobin (a protein that is used up mopping up free hemoglobin), point toward hemolysis. The next step is finding the cause, because that decides treatment. The direct antiglobulin test, also called the Coombs test, checks whether antibodies are coating the red cells and separates immune causes from other causes. A blood smear, in which the cells are examined under a microscope, can show shapes typical of particular conditions, such as fragmented cells when small-vessel clots are involved. Depending on the findings, a clinician may add hemoglobin studies, enzyme tests, genetic testing, a urine test or occasionally a bone marrow test, and will review recent medicines, infections and family history.

Treatment Options

Treatment depends on the type of hemolytic anemia and how fast red cells are being lost. Mild hemolysis may need only monitoring. When a medicine or an infection is responsible, stopping the medicine or treating the infection can resolve the anemia. Whatever the cause, a blood transfusion can quickly restore red cells when anemia is severe, and folic acid is often given because the marrow needs more of it to keep up production. For warm autoimmune hemolytic anemia, the most common immune type, corticosteroids such as prednisone are the usual first treatment because they calm the antibody attack. Rituximab (Rituxan and similar products), an antibody medicine that targets B cells, the immune cells that produce antibodies, is added early when the anemia is severe or steroids do not work promptly. Long steroid courses carry real side effects, so the goal is usually to taper them once the anemia is controlled. Much of this guidance rests on expert consensus because large trials are few. Cold agglutinin disease, an immune type in which antibodies attack red cells at cooler temperatures, is managed differently. Keeping the head, face, hands and feet warm reduces red cell breakdown. When treatment is needed, rituximab-based therapy is a common first choice. Sutimlimab (Enjaymo), an infusion that blocks part of the immune system called complement, is approved for hemolysis in adults with this condition; it raises the risk of serious infections, so vaccinations are brought up to date before starting. For some inherited and immune types, surgery to remove the spleen (splenectomy) reduces how many red cells are filtered out and destroyed, though it raises the risk of certain infections afterward. Inherited conditions such as sickle cell disease, thalassemia and G6PD deficiency have their own specific care, which for G6PD deficiency centers on avoiding the medicines and foods that trigger episodes.

What to Expect

The course depends heavily on the cause. Hemolysis triggered by a medicine or infection often clears once the trigger is gone. Autoimmune hemolytic anemia may settle with treatment and stay quiet, or it may relapse and need further rounds of treatment over years. Inherited forms are usually lifelong, with periods of stability punctuated by flares, often around infections. During active hemolysis, regular blood tests track hemoglobin and markers of red cell breakdown to show whether treatment is working and when it can be eased. Energy often improves as hemoglobin rises. Severe anemia puts extra strain on the heart and can worsen existing heart or lung disease, which is one reason clinicians aim to control it rather than simply live with it. For people with inherited forms or cold agglutinin disease, learning personal triggers, such as particular medicines, infections or cold exposure, becomes part of everyday planning.

When to Seek Help

Arrange an appointment if you have ongoing tiredness, weakness or breathlessness on exertion, or notice yellowing of the skin or eyes or unusually dark urine, especially after starting a new medicine or during an infection. If you already have hemolytic anemia, contact your care team promptly if these signs return or worsen, since this can mean a flare. Seek emergency care for severe weakness, a heart pounding hard and fast, or trouble catching your breath, which can mean red cells are being destroyed very quickly. Thrombotic thrombocytopenic purpura (TTP), one cause of small-vessel hemolysis, is life-threatening and needs hospital treatment right away: confusion, speech changes, a seizure or stroke-like symptoms, or new purple bruises or tiny red dots on the skin alongside yellowing or tiredness also call for emergency care.

Questions to Ask Your Doctor

  1. 1.What is causing my red blood cells to break down, and is it inherited or acquired?
  2. 2.Could any of my medicines, supplements or recent infections be contributing?
  3. 3.Which test results will show whether treatment is working, and how often will we check them?
  4. 4.What are the trade-offs of the treatment you recommend, and what would we try if it does not work?
  5. 5.Is there anything I should avoid, such as cold exposure, certain foods or particular medicines?

Last reviewed • Oct 2026

Educational content, not medical advice.